MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc. [electronic resource]
Producer: 20201126Description: 109962 p. digitalISSN:- 1950-6007
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival
- DNA-Binding Proteins -- genetics
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm
- Epithelial-Mesenchymal Transition -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lung Neoplasms -- drug therapy
- Mice
- Mice, Nude
- MicroRNAs -- genetics
- Neoplasms, Experimental -- drug therapy
- Transcription Factors -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.